VC and PE-backed Ikaria on the block for more than $2 bln

Ikaria Inc, a private equity and venture capital-backed company whose products are focused on critically ill patients, is exploring a sale that it hopes could value it at more than $2 billion, three people familiar with the matter said, sister news service Reuters reported.